FMNL2 is a member of diaphanous-related formins which control actin-dependent processes such as cell motility and invasion. Its over-expression in metastatic cell lines and tissues of colorectal carcinoma has been associated with aggressive tumor development in our previous study. But its specific role in cancer is largely unknown.
INTRODUCTION
Epithelial-mesenchymal transition (EMT) is a morphogenetic process in which cells lose their epithelial characteristics such as cell polarity, cell-cell contact, and gain mesenchymal properties such as increased motility [1] . EMT was originally described during embryogenesis [2] in developmental processes such as gastrulation, renal organogenesis, and the formation of neural crest [3] . Accumulating evidence has
shown that EMT is reactivated in a variety of conditions including cancer progression and metastasis [4] . At the molecular level, EMT is defined by the loss of cell-cell adhesion molecules (e.g., E-cadherin), down-regulation of epithelial differentiation markers, and transcriptional induction of mesenchymal markers, such as vimentin and fibronectin. Transforming growth factor-β (TGF-β) was first described as the inducer of EMT in normal mammary epithelial cells (MECs) [5] and now is recognized as a master regulator of EMT in a variety of cell types and tissues [6] .
FMNL2 is a member of the diaphanous-related formins (DRFs) that are key regulators of the actin cytoskeleton and act as effectors of Rho family guanosine triphosphatases (GTPases) [7, 8] . Recently, DRFs have emerged as a diverse family of ubiquitous, highly conserved multidomain proteins involved in a growing range of cellular processes including filopodium formation, cell migration, cytokinesis, cell adhesion, and cell polarity [9, 10] , which are frequently deregulated during pathological situations such as tumor cell transformation and metastasis [11] [12] [13] . Currently, some of DRFs, such as mDia1, have been reported to be critically involved in cancer cell
Real-time PCR assays.
Total RNA was extracted using Trizol reagent (Invitrogen, USA) and cDNA was synthesized by oligo dT primed reverse transcription from 2μg of total RNA using an access RT system (Promega, USA). Reverse transcription was carried out for 20min at 42°C. Real-time PCR was performed using Mx3000P Real-time PCR System (Stratagene) and SYBR PremixEx TaqTM (TaKaRa), using the following thermal cycling profile: pre-degeneration at 95°C for 10s, followed by 50 cycles of amplification (95°C for 30s, predicted TM value for 30s, 72°C for 30s). The dissociation curve analysis was used to validate the amplification of a single product.
Each reaction consisted of 12.5μl SYBR Premix ExTaq TM , 2μl cDNA template, 0.5μl each primer set (10μM), and 9.5μl nuclease-free water. Relative quantity of target transcripts in each sample was expressed as N-fold differences relative to control, or GCC ATT CAA GAC GTG GCA AAT CGC TCC TCC AGT TTT TTG TCG ACA -3'), siRNA2 (sense, 5'-GAT CCG CCT ACC TCC TGA CAA AGC CTT CAA GAC GGG CTT TGT CAG GAG GTA GGT TTT TTG TCG ACA -3'). The two pairs of double-stranded DNA were cloned into plasmid vector Pgenesil- [22] reported that the FH2 domain of Dia1 could promote stress fiber formation and transcriptional activation of the MAL/SRF pathway through its actin-polymerizing activity. The functional FH1-FH2-DAD (CT) domain of FMNL2 was amplified by nested PCR and then inserted into the pcDNA3/Flag (Invitrogen). Outer primers:
forward 5'-CAT TGT CCA TGG GGT CAG AAG T-3', reverse 5'-GGC AGT TTC
ATT CAC GCA CA-3'；inner primers: forward 5'-AAC GGT ACC CCC TTG CCC CCT CCT CCA CC-3', reverse 5'-CCA CTC GAG TCA CAT TGT TAT TTC GGC ACC-3'. The PCR conditions were as follows, 95°C for 3 min, followed by 30 cycles of amplification (94°C for 30s, 55°C for 40s with outer primers or 68°C for 40s with inner primers, 72°C for 2min). The correct coding regions of all plasmids were confirmed by sequencing. Transient transfection was performed using Lipofectamine (Invitrogen, Carlsbad, CA) as vehicle according to the manufacturer's instructions.
The plate was incubated for 48 hrs until it was ready for further assay.
In vitro invasion assay. In vitro invasive ability was tested by Boyden Chamber assay. Invasion Chamber has 8μm-pores in the PET membrane which is coated with matrigel (BD Biosciences, USA). Firstly, the invasion chambers were rehydrated with RPMI 1640 (serumfree) for 2h at 37℃ in 50 ml/L CO 2 atmosphere. RPMI 1640 with 100 ml/L fetal bovine serum was added to the lower compartment as the chemotactic were established by in vivo selection and had the high hepatic metastatic ability [20] .
RESULTS

Expression
Results of real-time PCR indicated that the expression of FMNL2 and vimentin in highly metastatic SW620 and SW480/M5 cell lines was higher than in lowly metastatic SW480 and HT29 cells, while E-Cadherin was inversely expressed (P<0.05, Fig.1A ). Western blot analysis confirmed the similar changes in these cell lines (Fig. 1B) . Results of cell IHC showed that in the lowly metastatic SW480 and HT29 cell lines, FMNL2 and vimentin were expressed at low levels. But highly metastatic SW620 and SW480/M5 cells had increasing expression of vimentin and reduced expressions of E-cadherin (Fig. 1C ).
To investigate the involvement of FMNL2 in EMT in vivo, we then examined the expression status of FMNL2, E-cadherin and vimentin in archived paraffin-embedded human CRC tissues, normal tissues, metastatic lymph nodes and livers. The expression of FMNL2 was gradually increased in normal mucosa, CRC tissues, metastatic lymph nodes and livers. The expression of FMNL2 in CRC tissues was higher than in normal mucosa (P<0.01) and high levels of FMNL2 expression were observed in metastatic lymph nodes and livers compared to those in CRC tissues (P＝ 0.017) ( Fig. 2A, tab1 ). Expression of E-cadherin was mostly found in normal mucosa, while there seemed to be very low levels of FMNL2 in the control tissues. The expression of E-cadherin was decreased or even lost in CRC tissues, lymphatic and hepatic metastases. E-cadherin was expressed more highly in normal mucosa than in CRC tissues (P<0.01). But there was no significant difference in E-cadherin expression between CRC tissues and metastatic lymph nodes or livers (P=0.187) ( 
Requirement of FMNL2 for maintaining the mesenchymal state of CRC cells.
To determine whether FMNL2 plays a contributory role in CRC invasion by inducing EMT, we knocked-down FMNL2 using two specific siRNAs. Western blot analysis confirmed that FMNL2 were depleted by the specific knockdown in SW480/M5 and SW480 cells (Fig.3A) . Cell death, which was assessed by trypan blue staining, did not increase in these knockdown cells (Fig.3B) . We observed that SW480/M5 and SW480 cells developed morphological changes under the FMNL2 knockdown ( Then we detected the expressions of MET markers following FMNL2 silencing.
E-cadherin was up-regulated in both FMNL2-depleting cells compared to mock cells, while vimentin was down-regulated in FMNL2-depleting cells by real-time RT-PCR (P<0.05), suggesting a switch to the epithelial state under FMNL2 knockdown (Fig.   3C,3D ). Western blot analysis further showed that the expression of E-cadherin was increased in FMNL2-depleting M5 and SW480 cells, while that of vimentin was decreased. Another two EMT epithelial markers α-catenin and γ-catenin were also found to be increasingly expressed in FMNL2-depleting M5 and SW480 cells. In addition, FMNL2 knockdown caused decrease of two EMT-stimulating transcription factors Snail and Slug in FMNL2-depleting cells (Fig. 3E ). These data suggest that FMNL2 is actively involved in maintaining EMT in CRC cells.
FMNL2 is involved in TGF-β-induced EMT and CRC cell invasion.
Multiple signal transduction pathways have been identified to be involved in the induction of EMT. Previous reports showed that TGF-β signaling promotes the metastasizing and invasive properties of some cancers, presumably by inducing EMT of the cells [23] .
TGF-β elicits EMT and in vivo metastasis via Smads and complementary non-Smad effectors, such as Rho GTPases and p38 MAPK [24] . In CRC, it was reported that TGF-β itself is overexpressed [25] . and can undergo typical morphological changes of EMT induced by TGF-β [26] .
MDCK cells appeared spindle-shaped and fibroblastic-like instead of the cobblestone-like phenotype induced by TGF-β. FMNL2-depleting cells represented mixed fibroblast-like and epithelial cells, and obviously had less fibroblast-like cells than mock cells (Fig. 4A) . Loss of FMNL2 expression lowered the ability of TGF-β to induce a spindle-like cell shape.
Second, we detected the altered expressions of EMT-markers induced by TGF-β.
At the mRNA level, TGF-β induced EMT over a period of 24h or 48h was reflected post application (Fig. 5D) . However, the expression changes of these markers were not obvious in M5/FMNL2 -cells as compared to those in M5 and MDCK cells ( situations such as tumor cell transformation and metastasis [27] . Three members of the DRF family (DRF1-DRF3) are reported to be required for invadopodia formation and invasion of breast tumor cells [28] . FMNL2 was identified as a candidate metastasis associated gene in our previous study [19] . However, the precise role of FMNL2 in mediating tumor cell invasion and metastasis has not been investigated.
EMT is characterized by the disassembly of cell-cell contacts, reorganization of the actin cytoskleleton, and cell-cell separation by reduced E-cadherin expression and β-catenin relocalization. As defined by E. Hay [29] , EMT results in the complex loss of epithelial traits (including loss of E-cadherin, plakoglobin and cytokeratins, and the dismantling of adherens junctions and desmosomes), accompanied by the total acquisition of mesenchymal characteristics, including expression of vimentin, N-cadherin, fibronectin and an elongated "fibroblast-like" morphology with capacity to execute invasive motility [30] . E-cadherin expression is irreversibly lost in invasive lobular breast cancer [31] . The cytoplasmic/nuclear re-localization of beta-catenin from the adherens and tight junctions is a common process in the epithelial-mesenchymal transition (EMT) associated with tumor invasion [32] . This transition is considered to be an important event during malignant tumor progression and metastasis [33, 34] .
To determine the involvement of FMNL2 with EMT of CRC, we firstly detected Consistent with the morphologic change, E-Cadherin、α-catenin and γ-catenin were increased while vimentin was reduced or even lost during the transition.
Transcriptional factors like snail [35] , slug [36] and Twist [37] were unveiled as key regulators in induction of EMT. We discovered that FMNL2 knockdown also inhibited the expression of snail and slug.
Several growth factors like transforming growth factor (TGF-β), hepatocyte growth factor (HGF), and matrix metalloproteinase (MMP-3) have been reported to induce EMT and to be associated with a more invasive phenotype in pancreatic cancer [38] [39] [40] .
TGF-β was first described as inducer of EMT in normal mammary epithelial cells (MECs) [5] and is now recognized as a master regulator of EMT in a variety of cell types and tissues [6] . In various tumor cell line, TGF-β signaling induces snail, slug and SIP1, which may then proceed to repress the expression of E-cadherin [35] .
Our study reveals that FMNL2, in association with the TGF-β signaling pathway, is required for maintenance of invasive ability and the mesenchymal state in CRC cells. . PI3K/Akt-dependent signaling pathways served to regulate hypoxia-induced EMT of hepatocellular carcinoma cells [42] . Also well documented was the fact that the Ras-RAF-MAPK pathway played an indispensable role in EMT induced by activation of receptor tyrosine kinase of growth factors like HGF, VEGF, EGF, and bFGF [18, 43] . Finally, we determined the 
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